Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1963
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 3
1965 1
1967 5
1968 7
1969 8
1970 6
1971 8
1972 10
1973 4
1974 13
1975 9
1976 11
1977 5
1978 3
1979 5
1980 9
1981 6
1982 3
1983 4
1984 9
1985 8
1986 7
1987 9
1988 17
1989 21
1990 20
1991 8
1992 24
1993 16
1994 26
1995 28
1996 23
1997 17
1998 18
1999 26
2000 19
2001 24
2002 17
2003 20
2004 32
2005 22
2006 26
2007 25
2008 22
2009 25
2010 27
2011 27
2012 34
2013 26
2014 32
2015 30
2016 41
2017 44
2018 32
2019 25
2020 32
2021 33
2022 35
2023 37
2024 37
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,052 results

Results by year

Filters applied: . Clear all
Page 1
Malignant Hypertension: Current Perspectives and Challenges.
Boulestreau R, van den Born BH, Lip GYH, Gupta A. Boulestreau R, et al. J Am Heart Assoc. 2022 Apr 5;11(7):e023397. doi: 10.1161/JAHA.121.023397. Epub 2022 Mar 15. J Am Heart Assoc. 2022. PMID: 35289189 Free PMC article. Review.
Malignant hypertension is a hypertensive emergency, with rapid disease progression and poor prognosis. ...
Malignant hypertension is a hypertensive emergency, with rapid disease progression and poor prognosis. ...
Management of hypertensive crisis: British and Irish Hypertension Society Position document.
Kulkarni S, Glover M, Kapil V, Abrams SML, Partridge S, McCormack T, Sever P, Delles C, Wilkinson IB. Kulkarni S, et al. J Hum Hypertens. 2023 Oct;37(10):863-879. doi: 10.1038/s41371-022-00776-9. Epub 2022 Nov 22. J Hum Hypertens. 2023. PMID: 36418425 Free PMC article. Review.
Patients with hypertensive emergencies, malignant hypertension and acute severe hypertension are managed heterogeneously in clinical practice. ...This position paper by British and Irish Hypertension Society, aims to provide clinicians a framework for …
Patients with hypertensive emergencies, malignant hypertension and acute severe hypertension are managed heterogeneousl …
Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
Boulestreau R, Śpiewak M, Januszewicz A, Kreutz R, Guzik TJ, Januszewicz M, Muiesan ML, Persu A, Sarafidis P, Volpe M, Zaleska-Żmijewska A, van den Born BH, Messerli FH. Boulestreau R, et al. J Am Coll Cardiol. 2024 Apr 30;83(17):1688-1701. doi: 10.1016/j.jacc.2024.02.037. J Am Coll Cardiol. 2024. PMID: 38658108 Review.
Malignant hypertension (MHT) is a hypertensive emergency with excessive blood pressure (BP) elevation and accelerated disease progression. ...
Malignant hypertension (MHT) is a hypertensive emergency with excessive blood pressure (BP) elevation and accelerated disease
Secondary Hypertension: Discovering the Underlying Cause.
Charles L, Triscott J, Dobbs B. Charles L, et al. Am Fam Physician. 2017 Oct 1;96(7):453-461. Am Fam Physician. 2017. PMID: 29094913 Free article. Review.
Most patients with hypertension have no clear etiology and are classified as having primary hypertension. However, 5% to 10% of these patients may have secondary hypertension, which indicates an underlying and potentially reversible cause. ...In adults 65 yea …
Most patients with hypertension have no clear etiology and are classified as having primary hypertension. However, 5% to 10% o …
Clinical Evaluation and Management of Thrombotic Microangiopathy.
Leisring J, Brodsky SV, Parikh SV. Leisring J, et al. Arthritis Rheumatol. 2024 Feb;76(2):153-165. doi: 10.1002/art.42681. Epub 2023 Nov 30. Arthritis Rheumatol. 2024. PMID: 37610060 Review.
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are traditionally considered to be primary forms of TMA, but TMA more commonly occurs in association with a coexisting condition such as infection, pregnancy, autoimmune disease, or malignant hypertension
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are traditionally considered to be primary forms of TMA, but TMA more comm …
Management of hypertensive emergencies and urgencies: narrative review.
Jolly H, Freel EM, Isles C. Jolly H, et al. Postgrad Med J. 2023 May 19;99(1169):119-126. doi: 10.1136/postgradmedj-2021-140899. Postgrad Med J. 2023. PMID: 37222066 Review.
Hypertensive emergencies, with the notable exception of uncomplicated malignant hypertension, require intravenous antihypertensive medication which is most safely given in high dependency or intensive care settings. ...
Hypertensive emergencies, with the notable exception of uncomplicated malignant hypertension, require intravenous antihyperten …
Malignant MCA Infarction: Pathophysiology and Imaging for Early Diagnosis and Management Decisions.
Heiss WD. Heiss WD. Cerebrovasc Dis. 2016;41(1-2):1-7. doi: 10.1159/000441627. Epub 2015 Nov 19. Cerebrovasc Dis. 2016. PMID: 26581023 Review.
BACKGROUND: Malignant middle cerebral artery infarction is a devastating condition, with up to 80% mortality in conservatively treated patients. ...Treatment options of malignant infarction include general measures to limit the extent of space-occupying edema, but t …
BACKGROUND: Malignant middle cerebral artery infarction is a devastating condition, with up to 80% mortality in conservatively treate …
Neonatal hypertension.
Sharma D, Farahbakhsh N, Shastri S, Sharma P. Sharma D, et al. J Matern Fetal Neonatal Med. 2017 Mar;30(5):540-550. doi: 10.1080/14767058.2016.1177816. Epub 2016 May 5. J Matern Fetal Neonatal Med. 2017. PMID: 27072362 Review.
Neonatal hypertension (HT) is a frequently under reported condition and is seen uncommonly in the intensive care unit. ...This review article covers multiple aspects of neonatal hypertension like definition, normotensive data, various etiologies and methods of BP me …
Neonatal hypertension (HT) is a frequently under reported condition and is seen uncommonly in the intensive care unit. ...This review …
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.
Fakhouri F, Frémeaux-Bacchi V. Fakhouri F, et al. Nat Rev Nephrol. 2021 Aug;17(8):543-553. doi: 10.1038/s41581-021-00424-4. Epub 2021 May 5. Nat Rev Nephrol. 2021. PMID: 33953366 Review.
The potential relevance of complement genetics for distinguishing the underlying mechanisms of malignant hypertension-associated TMA should be assessed with caution owing to the overlap between aHUS and other causes of malignant hypertension. ...
The potential relevance of complement genetics for distinguishing the underlying mechanisms of malignant hypertension-associat …
Scleroderma renal crisis.
Hudson M, Ghossein C, Steen V. Hudson M, et al. Presse Med. 2021 Apr;50(1):104063. doi: 10.1016/j.lpm.2021.104063. Epub 2021 Feb 3. Presse Med. 2021. PMID: 33548376 Review.
Scleroderma renal crisis (SRC) is a rare but life-threatening complication of systemic sclerosis (SSc) characterized by malignant hypertension and acute kidney injury. Historically, SRC was the leading cause of death in SSc. ...Specific issues relating to pregnancy, …
Scleroderma renal crisis (SRC) is a rare but life-threatening complication of systemic sclerosis (SSc) characterized by malignant
1,052 results